In clinical trials, the impact of DUPIXENT on lung function was studied in patients 6 to 11 years of age and patients 12 years of age and older. Patients in each age group saw improved lung function in as little as 2 weeks.

Learn how DUPIXENT helped treat children 6 to 11 years old with their moderate-to-severe asthma.

RESULTS IN CHILDREN
AGES 6-11 YEARS